92 related articles for article (PubMed ID: 31359385)
61. In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome.
Sinha A; Ignatchenko V; Ignatchenko A; Mejia-Guerrero S; Kislinger T
Biochem Biophys Res Commun; 2014 Mar; 445(4):694-701. PubMed ID: 24434149
[TBL] [Abstract][Full Text] [Related]
62. Poly r(C) Binding Protein 1 Regulates Posttranscriptional Expression of the Ubiquitin Ligase TRIM56 in Ovarian Cancer.
Zhao L; Wang ZG; Zhang P; Yu XF; Su XJ
IUBMB Life; 2019 Feb; 71(2):177-182. PubMed ID: 30281912
[TBL] [Abstract][Full Text] [Related]
63. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
64. Proteomic analysis of a highly metastatic gastric cancer cell line using two-dimensional differential gel electrophoresis.
Takikawa M; Akiyama Y; Maruyama K; Suzuki A; Liu F; Tai S; Ohshita C; Kawaguchi Y; Bandou E; Yonemura Y; Yamaguchi K
Oncol Rep; 2006 Oct; 16(4):705-11. PubMed ID: 16969483
[TBL] [Abstract][Full Text] [Related]
65. Clinical proteomics in cancer research-promises and limitations of current two-dimensional gel electrophoresis.
Iwadate Y
Curr Med Chem; 2008; 15(23):2393-400. PubMed ID: 18855668
[TBL] [Abstract][Full Text] [Related]
66. Proteomic analysis of a preneoplastic phenotype in ovarian surface epithelial cells derived from prophylactic oophorectomies.
He QY; Zhou Y; Wong E; Ehlen TG; Auersperg N; Chiu JF; Wong AS
Gynecol Oncol; 2005 Jul; 98(1):68-76. PubMed ID: 15913737
[TBL] [Abstract][Full Text] [Related]
67. Proteomic identification of tumor-associated protein in ovarian serous cystadenocarinoma.
Li XQ; Zhang SL; Cai Z; Zhou Y; Ye TM; Chiu JF
Cancer Lett; 2009 Mar; 275(1):109-16. PubMed ID: 19056166
[TBL] [Abstract][Full Text] [Related]
68. MALDI-TOF-MS analysis in discovery and identification of serum proteomic patterns of ovarian cancer.
Swiatly A; Horala A; Hajduk J; Matysiak J; Nowak-Markwitz E; Kokot ZJ
BMC Cancer; 2017 Jul; 17(1):472. PubMed ID: 28683725
[TBL] [Abstract][Full Text] [Related]
69. MicroRNA-137 suppresses tumor growth in epithelial ovarian cancer in vitro and in vivo.
Zhang L; Li Z; Gai F; Wang Y
Mol Med Rep; 2015 Aug; 12(2):3107-14. PubMed ID: 25955305
[TBL] [Abstract][Full Text] [Related]
70. ER-60 (PDIA3) is highly expressed in a newly established serous ovarian cancer cell line, YDOV-139.
Chay D; Cho H; Lim BJ; Kang ES; Oh YJ; Choi SM; Kim BW; Kim YT; Kim JH
Int J Oncol; 2010 Aug; 37(2):399-412. PubMed ID: 20596667
[TBL] [Abstract][Full Text] [Related]
71. [Monitoring changes of serum protein markers in metastatic colorectal carcinoma model].
Li ZG; Zhao L; Liu L; Ding YQ
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):48-52. PubMed ID: 17374239
[TBL] [Abstract][Full Text] [Related]
72. Circular RNA ITCH suppresses proliferation and promotes apoptosis in human epithelial ovarian cancer cells by sponging miR-10a-α.
Luo L; Gao YQ; Sun XF
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8119-8126. PubMed ID: 30556849
[TBL] [Abstract][Full Text] [Related]
73. ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells.
Llauradó M; Abal M; Castellví J; Cabrera S; Gil-Moreno A; Pérez-Benavente A; Colás E; Doll A; Dolcet X; Matias-Guiu X; Vazquez-Levin M; Reventós J; Ruiz A
Int J Cancer; 2012 Apr; 130(7):1532-43. PubMed ID: 21520040
[TBL] [Abstract][Full Text] [Related]
74. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis.
Long X; Song K; Hu H; Tian Q; Wang W; Dong Q; Yin X; Di W
J Exp Clin Cancer Res; 2019 Aug; 38(1):345. PubMed ID: 31391118
[TBL] [Abstract][Full Text] [Related]
75. [Proteomic study of total protein of Pinellia pedatisecta Schott effect on human ovarian cancer SKOV3 cells].
Chen XY; Zhou L; Zheng FY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Dec; 31(12):1651-6. PubMed ID: 22384553
[TBL] [Abstract][Full Text] [Related]
76. Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer.
Joseph C; Al-Izzi S; Alsaleem M; Kurozumi S; Toss MS; Arshad M; Goh FQ; Alshankyty IM; Aleskandarany MA; Ali S; Ellis IO; Mongan NP; Green AR; Rakha EA
Br J Cancer; 2019 Oct; 121(9):776-785. PubMed ID: 31558802
[TBL] [Abstract][Full Text] [Related]
77. Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics.
Anand U; Dey A; Chandel AKS; Sanyal R; Mishra A; Pandey DK; De Falco V; Upadhyay A; Kandimalla R; Chaudhary A; Dhanjal JK; Dewanjee S; Vallamkondu J; Pérez de la Lastra JM
Genes Dis; 2023 Jul; 10(4):1367-1401. PubMed ID: 37397557
[TBL] [Abstract][Full Text] [Related]
78. Proteomics to Predict Loss of RXR-γ During Progression of Epithelial Ovarian Cancer.
Kalra RS; Bapat SA
Methods Mol Biol; 2019; 2019():1-14. PubMed ID: 31359385
[TBL] [Abstract][Full Text] [Related]
79. Expression proteomics predicts loss of RXR-γ during progression of epithelial ovarian cancer.
Kalra RS; Bapat SA
PLoS One; 2013; 8(8):e70398. PubMed ID: 23936423
[TBL] [Abstract][Full Text] [Related]
80. [Identification of metastasis-associated proteins of ovarian cancer by proteomics].
Zhou L; Yang XF; Wang Y; Zhang YT; Geng YP; Si LS; Wang YL
Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):814-8. PubMed ID: 18346353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
